AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 9,350.00
-30.00 (-0.32%)
Dec 30, 2025, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 261.04 billion as of December 30, 2025. Its market cap has increased by 48.94% in one year.
Market Cap
261.04B
Enterprise Value
250.26B
Revenue
3.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,350.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 261.04B, a decrease of -38.33%. That is a compound annual growth rate of -7.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 261.88B | 52.94% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |